Insight

Aug 12, 2024, 09:21

Giuseppe Banna: RBC-based scores improving prognostic systems in metastatic RCC

Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, recently shared a post on X about a recent paper published in Immunotherapy.

“A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study”

Authors: Shobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, Giulia Mazzaschi, Sebastiano Buti et al.

“The potential of RBC-based scores to improve prognostic systems in metastatic renal cell carcinoma. Identifying patients with better prognosis and exploring molecular correlates could refine treatment strategies.

A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study: Immunotherapy: Vol 0, No 0 – Get Access.”

Source: Giuseppe Banna/X

More posts by Giuseppe Banna in OncoDaily.

cancer Giulia Mazzaschi Giuseppe Luigi Banna immunotherapy metastatic renal cell carcinoma OncoDaily Oncology Portsmouth Hospitals University NHS Trust RCC Sara Elena Rebuzzi Sebastiano Buti Shobana Anpalakhan Treatment Strategies

Shannon Miller and Ovarian Cancer: How She Went Against, How She Survived, and More

ASTRO Overview: Everything You Need to Know About the Leading Radiation Oncology Society

Kamala Harris vs Donald Trump on Cancer: From Cancer Moonshot to Right to Act, Funding, Research and Future

Dr. Richard Pazdur: 25 Years of Transforming Oncology Drug Development at the FDA

New €4.9m Beaumont RCSI Cancer Centre and Irish Cancer Society Partnership to Transform Lung Cancer Care in Ireland

Special Coverage